Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Hospital Acquired Infections (HAI) Diagnostics Market Growth (Status and Outlook) 2022-2028

  • LP 4923890
  • 63 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Hospital Acquired Infections (HAI) Diagnostics will have significant change from previous year. According to our (LP Information) latest study, the global Hospital Acquired Infections (HAI) Diagnostics market size is USD million in 2022 from USD 3259.4 million in 2021, with a change of % between 2021 and 2022. The global Hospital Acquired Infections (HAI) Diagnostics market size will reach USD 4409.4 million in 2028, growing at a CAGR of 4.4% over the analysis period.

The United States Hospital Acquired Infections (HAI) Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital Acquired Infections (HAI) Diagnostics market, reaching US$ million by the year 2028. As for the Europe Hospital Acquired Infections (HAI) Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Hospital Acquired Infections (HAI) Diagnostics players cover BioMérieux, Abbott Laboratories, Roche AG, and Siemens Healthcare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital Acquired Infections (HAI) Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Molecular Diagnostics Tests

Other In-vitro Diagnostic Tests

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Bloodstream Infections (BSI)

Urinary Tract Infections (UTI)

Surgical Site Infections (SSI)

Pneumonia

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

BioMérieux

Abbott Laboratories

Roche AG

Siemens Healthcare

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size 2017-2028

2.1.2 Hospital Acquired Infections (HAI) Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Hospital Acquired Infections (HAI) Diagnostics Segment by Type

2.2.1 Molecular Diagnostics Tests

2.2.2 Other In-vitro Diagnostic Tests

2.3 Hospital Acquired Infections (HAI) Diagnostics Market Size by Type

2.3.1 Hospital Acquired Infections (HAI) Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type (2017-2022)

2.4 Hospital Acquired Infections (HAI) Diagnostics Segment by Application

2.4.1 Bloodstream Infections (BSI)

2.4.2 Urinary Tract Infections (UTI)

2.4.3 Surgical Site Infections (SSI)

2.4.4 Pneumonia

2.4.5 Others

2.5 Hospital Acquired Infections (HAI) Diagnostics Market Size by Application

2.5.1 Hospital Acquired Infections (HAI) Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application (2017-2022)

3 Hospital Acquired Infections (HAI) Diagnostics Market Size by Player

3.1 Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Players

3.1.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Players (2020-2022)

3.1.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Players (2020-2022)

3.2 Global Hospital Acquired Infections (HAI) Diagnostics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Hospital Acquired Infections (HAI) Diagnostics by Regions

4.1 Hospital Acquired Infections (HAI) Diagnostics Market Size by Regions (2017-2022)

4.2 Americas Hospital Acquired Infections (HAI) Diagnostics Market Size Growth (2017-2022)

4.3 APAC Hospital Acquired Infections (HAI) Diagnostics Market Size Growth (2017-2022)

4.4 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Growth (2017-2022)

4.5 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022)

5.2 Americas Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022)

5.3 Americas Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2017-2022)

6.2 APAC Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022)

6.3 APAC Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Hospital Acquired Infections (HAI) Diagnostics by Country (2017-2022)

7.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022)

7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics by Region (2017-2022)

8.2 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022)

8.3 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.1 Global Hospital Acquired Infections (HAI) Diagnostics Forecast by Regions (2023-2028)

10.1.1 Global Hospital Acquired Infections (HAI) Diagnostics Forecast by Regions (2023-2028)

10.1.2 Americas Hospital Acquired Infections (HAI) Diagnostics Forecast

10.1.3 APAC Hospital Acquired Infections (HAI) Diagnostics Forecast

10.1.4 Europe Hospital Acquired Infections (HAI) Diagnostics Forecast

10.1.5 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Forecast

10.2 Americas Hospital Acquired Infections (HAI) Diagnostics Forecast by Country (2023-2028)

10.2.1 United States Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.2.2 Canada Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.2.3 Mexico Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.2.4 Brazil Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.3 APAC Hospital Acquired Infections (HAI) Diagnostics Forecast by Region (2023-2028)

10.3.1 China Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.3.2 Japan Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.3.3 Korea Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.3.4 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.3.5 India Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.3.6 Australia Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.4 Europe Hospital Acquired Infections (HAI) Diagnostics Forecast by Country (2023-2028)

10.4.1 Germany Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.4.2 France Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.4.3 UK Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.4.4 Italy Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.4.5 Russia Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.5 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Forecast by Region (2023-2028)

10.5.1 Egypt Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.5.2 South Africa Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.5.3 Israel Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.5.4 Turkey Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.5.5 GCC Countries Hospital Acquired Infections (HAI) Diagnostics Market Forecast

10.6 Global Hospital Acquired Infections (HAI) Diagnostics Forecast by Type (2023-2028)

10.7 Global Hospital Acquired Infections (HAI) Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 BioMérieux

11.1.1 BioMérieux Company Information

11.1.2 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product Offered

11.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 BioMérieux Main Business Overview

11.1.5 BioMérieux Latest Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Information

11.2.2 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product Offered

11.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Abbott Laboratories Main Business Overview

11.2.5 Abbott Laboratories Latest Developments

11.3 Roche AG

11.3.1 Roche AG Company Information

11.3.2 Roche AG Hospital Acquired Infections (HAI) Diagnostics Product Offered

11.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Roche AG Main Business Overview

11.3.5 Roche AG Latest Developments

11.4 Siemens Healthcare

11.4.1 Siemens Healthcare Company Information

11.4.2 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product Offered

11.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Siemens Healthcare Main Business Overview

11.4.5 Siemens Healthcare Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Hospital Acquired Infections (HAI) Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Molecular Diagnostics Tests

Table 3. Major Players of Other In-vitro Diagnostic Tests

Table 4. Hospital Acquired Infections (HAI) Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type (2017-2022)

Table 7. Hospital Acquired Infections (HAI) Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application (2017-2022)

Table 10. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Player (2020-2022)

Table 12. Hospital Acquired Infections (HAI) Diagnostics Key Players Head office and Products Offered

Table 13. Hospital Acquired Infections (HAI) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Regions (2017-2022)

Table 18. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Country (2017-2022)

Table 20. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type (2017-2022)

Table 22. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application (2017-2022)

Table 24. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Region (2017-2022)

Table 26. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type (2017-2022)

Table 28. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application (2017-2022)

Table 30. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Country (2017-2022)

Table 32. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type (2017-2022)

Table 34. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Hospital Acquired Infections (HAI) Diagnostics

Table 43. Key Market Challenges & Risks of Hospital Acquired Infections (HAI) Diagnostics

Table 44. Key Industry Trends of Hospital Acquired Infections (HAI) Diagnostics

Table 45. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share Forecast by Application (2023-2028)

Table 51. BioMérieux Details, Company Type, Hospital Acquired Infections (HAI) Diagnostics Area Served and Its Competitors

Table 52. BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product Offered

Table 53. BioMérieux Hospital Acquired Infections (HAI) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. BioMérieux Main Business

Table 55. BioMérieux Latest Developments

Table 56. Abbott Laboratories Details, Company Type, Hospital Acquired Infections (HAI) Diagnostics Area Served and Its Competitors

Table 57. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product Offered

Table 58. Abbott Laboratories Main Business

Table 59. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Abbott Laboratories Latest Developments

Table 61. Roche AG Details, Company Type, Hospital Acquired Infections (HAI) Diagnostics Area Served and Its Competitors

Table 62. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product Offered

Table 63. Roche AG Main Business

Table 64. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Roche AG Latest Developments

Table 66. Siemens Healthcare Details, Company Type, Hospital Acquired Infections (HAI) Diagnostics Area Served and Its Competitors

Table 67. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product Offered

Table 68. Siemens Healthcare Main Business

Table 69. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Siemens Healthcare Latest Developments

List of Figures

Figure 1. Hospital Acquired Infections (HAI) Diagnostics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type in 2021

Figure 7. Hospital Acquired Infections (HAI) Diagnostics in Bloodstream Infections (BSI)

Figure 8. Global Hospital Acquired Infections (HAI) Diagnostics Market: Bloodstream Infections (BSI) (2017-2022) & ($ Millions)

Figure 9. Hospital Acquired Infections (HAI) Diagnostics in Urinary Tract Infections (UTI)

Figure 10. Global Hospital Acquired Infections (HAI) Diagnostics Market: Urinary Tract Infections (UTI) (2017-2022) & ($ Millions)

Figure 11. Hospital Acquired Infections (HAI) Diagnostics in Surgical Site Infections (SSI)

Figure 12. Global Hospital Acquired Infections (HAI) Diagnostics Market: Surgical Site Infections (SSI) (2017-2022) & ($ Millions)

Figure 13. Hospital Acquired Infections (HAI) Diagnostics in Pneumonia

Figure 14. Global Hospital Acquired Infections (HAI) Diagnostics Market: Pneumonia (2017-2022) & ($ Millions)

Figure 15. Hospital Acquired Infections (HAI) Diagnostics in Others

Figure 16. Global Hospital Acquired Infections (HAI) Diagnostics Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application in 2021

Figure 18. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Player in 2021

Figure 19. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size 2017-2022 ($ Millions)

Figure 21. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size 2017-2022 ($ Millions)

Figure 22. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size 2017-2022 ($ Millions)

Figure 24. Americas Hospital Acquired Infections (HAI) Diagnostics Value Market Share by Country in 2021

Figure 25. Americas Hospital Acquired Infections (HAI) Diagnostics Consumption Market Share by Type in 2021

Figure 26. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application in 2021

Figure 27. United States Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Region in 2021

Figure 32. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application in 2021

Figure 33. China Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Country in 2021

Figure 40. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type in 2021

Figure 41. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application in 2021

Figure 42. Germany Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Market Share by Application in 2021

Figure 50. Egypt Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Hospital Acquired Infections (HAI) Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 56. APAC Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 57. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 59. United States Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 60. Canada Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 63. China Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 64. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 65. Korea Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 67. India Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 68. Australia Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 69. Germany Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 70. France Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 71. UK Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 72. Italy Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 73. Russia Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 74. Spain Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 77. Israel Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Hospital Acquired Infections (HAI) Diagnostics Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450